Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart

Canadian Journal of Physiology and Pharmacology
Aysu KilicEbru Gurel Gurevin

Abstract

Our study aimed to determine the effects of losartan and PD123319 in ischemia-reperfusion (IR) injury in isolated perfused rat heart. The study used 40 male Wistar albino rats that were grouped as Control, IR, and IR treatment groups that received losartan (20 mg/kg), PD123319 (20 mg/kg), and losartan+PD123319. The hearts were attached to Langendorff isolated heart system by employing in situ cannulation method, and cardiodynamic parameters were recorded during the experiment. At the end of experiment, hearts were retained for biochemical analysis and all data were statistically evaluated. A partial recovery of cardiodynamic parameters was observed in all treatment groups. A significant increase in oxidative stress parameters were seen in the IR group, whereas all treatment groups exhibited lower increase. Furthermore, levels of all antioxidant parameters were significantly lower in the IR group, but higher in the treatment groups. Effects on all parameters were much more remarkable in the PD123319 group. Levels of angiotensin II and renin were increased (P < 0.001) with IR application and decreased (P < 0.001) with the treatment of both antagonists. In conclusion, treatment of losartan and PD123319 played a cardioprotective ro...Continue Reading

References

Feb 1, 1981·The American Journal of Physiology·H V SchaffJ T Flaherty
Jun 17, 2000·Hypertension·W C De Mello, A H Danser
May 10, 2001·Journal of Molecular and Cellular Cardiology·Y SunK T Weber
Jan 18, 2003·Current Hypertension Reports·Marta Ruiz-OrtegaJesús Egido
Jun 12, 2003·Blood Pressure·Elena Kaschina, Thomas Unger
Dec 18, 2003·Clinical and Experimental Pharmacology & Physiology·Yi-Chun ZhuTai Yao
Oct 19, 2004·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Kylie VenardosAnthony Perkins
Jul 4, 2006·Physiological Reviews·Martin PaulReinhold Kreutz
Jun 23, 2007·Current Medicinal Chemistry·Kylie M VenardosDavid M Kaye
Apr 4, 2009·Nephron. Experimental Nephrology·Sara M MolinasLaura Trumper
Mar 27, 2010·Basic Research in Cardiology·Shizu OyamadaFrank W Sellke
Nov 26, 2010·Current Opinion in Nephrology and Hypertension·Chris TikellisWendy C Burns
Dec 17, 2010·Current Opinion in Pharmacology·Lie Gao, Irving H Zucker
Apr 20, 2011·Hypertension·Mazen Kurdi, George W Booz
Jul 7, 2011·Peptides·Walmor C De Mello, Edward D Frohlich
Jul 1, 2010·Pharmacognosy Reviews·V LoboN Chandra
Dec 27, 2012·The World Allergy Organization Journal·Esra BirbenOmer Kalayci
Mar 1, 2014·Circulation Research·Sasa Vukelic, Kathy K Griendling
Jul 30, 2014·Frontiers in Endocrinology·Duncan J Campbell
Sep 23, 2014·Iranian Red Crescent Medical Journal·Mahin DianatAlireza Samarbafzadeh
Oct 14, 2014·Naunyn-Schmiedeberg's Archives of Pharmacology·Alexandro HoyerStefan Dhein
Apr 17, 2015·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Mohsen Sharifi KlishadiFatemeh Safari
Oct 29, 2015·BioMed Research International·Tingyang ZhouLi Zuo
Apr 24, 2016·Therapeutic Advances in Cardiovascular Disease·Carlos M Ferrario
Jul 12, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Elena KaschinaThomas Unger
Jan 27, 2019·Experimental and Therapeutic Medicine·Bin ChengHong Jiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.